Advertisement

Topics

Latest "Dove Medical Press Limited" News Stories

11:01 EST 17th December 2018 | BioPortfolio

Here are the most relevant search results for "Dove Medical Press Limited" found in our extensive news archives from over 250 global news sources.

More Information about Dove Medical Press Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Dove Medical Press Limited for you to read. Along with our medical data and news we also list Dove Medical Press Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of Dove Medical Press Limited Companies for you to search.

Showing "Dove Medical Press Limited" News Articles 1–25 of 25,000+

Relevant

Dove, Dunkin’ partner for National Coffee Day


Dove launches No Digital Distortion Mark on branded content

Dove's No Digital Distortio

Dove Self-Esteem Project, Shonda Rhimes launch Girl Collective

Dove and Shonda Rhimes launched the G


Dove Chocolate’s new bars remix classic flavors

Dove Chocolate's new f

Blood biomarkers as a diagnostic tool for obstructive sleep apnea

(Dove Medical Press) Obstructive sleep apnea is a condition causing daytime tiredness which can significantly impact a patient's quality of life and increases the risk of cardiovascular disease and diabetes. It is a common, chronic disorder that affects thousands of patients, yet recent studies show that many sufferers remain undiagnosed.

SCYX Takes Wings On DOVE Data, IDRA/BCRX Merger Terminated, ADXS Hits New Low

Today's Daily Dose brings you news about SCYNEXIS' Dove study results; termination of the merger agreement between Idera and BioCryst Pharma; withdrawal of Advaxis' Conditional Marketing Authorization Application in the European Union for Axalimogene filolisbac and stock offering of ArQule.

A New Edition of Medical Law Review Is Now Available

Medical Law Review (vol. 26, no. 2, 2018) is available online by subscription only. Articles include: “When can the Child Speak for Herself? The Limits of Parental Consent in Data Protection Law for Health Research” by Mark J Taylor, Edward S Dove, … Read More

Study highlights potential use of blood biomarkers as diagnostic tool for sleep apnea

The Dove Medical Press journal, Nature and Science of Sleep, has published a study that highlights the potential use of blood biomarkers as a diagnostic tool for obstructive sleep apnea.

Fagron NV : Disclosure of received notification

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 31 July 2018 - 7:00am (CET) Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received the following notification. Notification of JPMorgan Asset Management Holdings Inc., received on 26 July 2018 On 26 July 2018, Fagron received a not...

Go-Dove auctions pharmaceutical manufacturing and packaging equipment

GoIndustry DoveBid offers buyers excellent deals on surplus assets in more than 500 categories, with thousands of items auctioned off every week. Major systems are available for immediate sale

Now THIS is fake health news – and it appears in major newspapers across the U.S.

The story began:  “It is not often that another country beats the US to a medical breakthrough.  So when it happens, you know it’s something special.” But buyer beware.  Because it’s not so special when the story is bylined from “The Associated Health Press.” That’s not the venerable Associated Press wire service.  It’s a copycat […]

MYM Announces Ribbon Cutting and Press Conference for 1.5 Million Square Foot Medical Cannabis Production Facility in Weedon, Quebec

VANCOUVER, British Columbia, June 18, 2018 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM.CN)(MYM.CN) ("MYM") is pleased to announce the ribbon cutting ceremony and press conference for its 1....

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ headquarters in New York earlier today. Following the recent announcement of positive field trial data in a European field trial, the Company met earlier today with investors and analysts at NASDAQ’...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July 16, 2018 from 9:00am – 1:00pm ET, in New York, NY. At the event, Franz Walt, Chief Executive Officer of Quotient Limited, along with other members of the management team, will provide a briefing on ...

Serious Candida Infections: Scynexis's Oral Antifungal Could Challenge Fluconazole

Positive top-line results from the Phase IIb DOVE study of Scynexis's SCY-078, and progress with a new intravenous formulation, suggest...    

Global Cannabidiol Oil (CBD Oil) Market 2018 -ENDOCA, Gaia Botanicals, Isodiol, Medical Marijuana, Aurora … – MRS News Journal (press release) (blog)

MRS News Journal (press release) (blog)Global Cannabidiol Oil (CBD Oil) Market 2018 -ENDOCA, Gaia Botanicals, Isodiol, Medical Marijuana, Aurora ...MRS News Journal (press release) (blog)The study on Global Cannabidiol Oil (CBD Oil) Market reports provides you comprehensive outlook. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, ...

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation (V&V) concordance data for its initial MosaiQ™ Serological Disease Screening (SDS) Microarray. Initial SDS Microarray – Assay Performance Results of the V&V head-to-head study for the ...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously announced underwritten public offering of 9,230,770 ordinary shares at a price to the public of $6.50 per share. The net proceeds to the Company from this offering are expected to be approximately $56.1 mi...

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an underwritten public offering of its ordinary shares. All of the ordinary shares to be sold in the offering will be offered by the Company. In addition, the Company intends to grant the underwriters a ...

Quotient Limited Announces Completion of Senior Secured Notes Offering

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million aggregate principal amount of its 12% Senior Secured Notes due 2023 (the “Notes”). On June 29, 2018, the Company, completed the second and final closing (the “Second Closing”) of...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop, will present at the Jefferies 2018 London Healthcare Conference on Tuesday, November 14th, 2018 at 8:40 a.m. GMT (3:40 a.m. Eastern Time). A webcast of the presentation will be available online ...

Quotient Limited Reports Concordance Data from the MosaiQ European Field Trial

Field trial concordance data exceed targeted criteriaPlanned issuance of $36 million in Senior Secured Notes JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported concordance data for the initial MosaiQ blood grouping microarray generated in its European field trial, which exceed the targeted criteria ...

Veritas Signs MOU with Israeli Cannabis Industry Leader IsCann Group Limited

VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has signed a Memorandum of Understanding (“MOU”) with IsCann Group Limited (“IsCann”) located in Be'er Tuvya, Israel with the aim of establishing, maintaining, and expanding business in the Canad...

Quotient Limited to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference

JERSEY, Channel Islands, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Franz Walt, will present at the 2018 Cantor Fitzgerald Global Healthcare Conference on Wednesday, October 3rd, 2018 at 4:00 p.m. EDT at The InterContinental New York Barclay Hotel, in New York, NY.  ...

Quotient Limited Announces Receipt of Consents to Modifications to the Company’s Senior Secured Notes

JERSEY, Channel Islands, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the receipt of consents from the holders of its Senior Secured Notes (the Notes) to certain amendments (the Proposed Amendments) to the indenture governing the Notes (the Indenture).    Franz Walt, Quotient’s Chief Executive Offi...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks